Toward the first drug to treat a rare, lethal liver cancer
Treatment options for a deadly liver cancer, fibrolamellar carcinoma, are severely lacking. Drugs that work…
Treatment options for a deadly liver cancer, fibrolamellar carcinoma, are severely lacking. Drugs that work…
Treatment options for a deadly liver cancer, fibrolamellar carcinoma, are severely lacking. Drugs that work…
Oncotarget published “Effect of cell microenvironment on the drug sensitivity of hepatocellular cancer cells” which…
Non-alcoholic fatty liver, NAFLD, is associated with several health risks. According to a new registry…
Researchers found for the first time that immunotherapy is significantly less effective in liver cancer…
In structural biology, some molecules are so unusual they can only be captured with a…
The IMbrave150 trial found median overall survival was 19.2 months in patients treated with atezo…
A liquid formulation can kill swathes of liver cancer cells and potentiate chemotherapy treatments, according…
The delays of screening programmes, diagnostic imaging and biopsies, cuts in the numbers of physicians…
People with non-alcohol-related liver cancer have a unique gut microbiome profile which could help predict…